Skip to main content
From Bio Co., Ltd. logo

From Bio Co., Ltd. — Investor Relations & Filings

Ticker · 377220 ISIN · KR7377220009 KO Manufacturing
Open in API
Filings indexed 112 across all filing types
Latest filing 2024-11-06 Director's Dealing
Country KR South Korea
Listing KO 377220

About From Bio Co., Ltd.

https://frombio-company.co.kr/default/e…

From Bio Co., Ltd. is a healthcare company specializing in the research, development, manufacturing, and sale of health functional foods and dietary supplements. The company operates across the entire value chain, from sourcing new raw materials to production in its GMP-certified facility. A significant focus is placed on research and development through its specialized Food, Bio, and New Drug laboratories. These divisions work on discovering and verifying novel functional ingredients for health foods while also developing new pharmaceuticals, including treatments for alopecia and first-in-class drugs. The product portfolio addresses specific health needs such as joint health (Boswellia), stomach comfort (Mastic Gum), eye health (Bilberry), and body fat reduction (Wild Mango), emphasizing the use of natural, plant-based ingredients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details share acquisitions by an executive (Shim Tae-jin) of FromBio. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives.
2024-11-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by a major shareholder (Shim Tae-jin) and their special related parties in the company 'FromBio'. This type of filing is specifically used to notify the market of significant changes in shareholding levels (crossing thresholds or major changes in ownership). In the provided classification schema, 'Major Shareholding Notification' (MRQ) is the correct category for such filings.
2024-11-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a director (Shim Tae-jin) of the company FromBio. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS).
2024-10-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share acquisition transactions (장내매수) by a company executive (Shim Tae-jin) of FromBio. This type of filing is a standard regulatory disclosure for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2024-10-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of regulatory filing is required when an individual or entity crosses a significant ownership threshold (typically 5%) in a publicly traded company. It details the shareholding status, changes in ownership, and the purpose of the holding (e.g., influencing management). Based on the provided filing categories, this document falls under 'Major Shareholding Notification'.
2024-10-11 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed by an executive (Shim Tae-Jin) of FromBio. This is a regulatory disclosure required by the Financial Services Commission and the Korea Exchange regarding planned insider transactions. Since it details personal share trading plans by a director/executive, it falls under the 'Director's Dealing' category.
2024-09-05 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.